Summary: This is a 10-month clinical research study to assess the safety and efficacy of an investigational (not approved by the FDA) medication for people with Crohn's disease.
Participation qualifications:Benefits:
Study participants may receive study-related examinations/procedures, laboratory testing, and study medication or placebo.
Reimbursement for time and travel is also available.
Participants cannot be enrolled in the clinical study until they have signed an informed consent form, completed screening, and have been fully evaluated at the study site.